Outcomes of patients with IDH1/2 mutated accelerated/blast-phase myeloproliferative neoplasms in the era of IDH inhibitors Meeting Abstract
| Authors: | Goldberg, L. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; Madarang, E.; Muthiah, C.; Kassner, J.; Rampal, R.; Murthy, G. S. G.; Bradley, T.; Abaza, Y.; Garcia, J. S.; Gupta, V.; Pettit, K. M.; Odenike, O.; Cursio, J. F.; Patel, A. A. |
| Abstract Title: | Outcomes of patients with IDH1/2 mutated accelerated/blast-phase myeloproliferative neoplasms in the era of IDH inhibitors |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 1787 |
| End Page: | 1789 |
| Language: | English |
| ACCESSION: | WOS:001414558300005 |
| DOI: | 10.1182/blood-2024-197898 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Hybrid event -- Source: Wos |
